Wink Biotherapeutics
June 23, 2026
5B
Type: Start-Up Stadium Session
Focus Area:
Regenerative Medicine
Wink Biotherapeutics is developing novel, RNA-based therapeutics that allow for a functional cure for diabetes. We are the only company in the world that allows for targeted pancreatic beta cell regeneration, long considered the 'Holy Grail' for potential diabetes cures.
Company HQ City:
Hallandale Beach
Company HQ State:
Florida
Company HQ Country:
United States
Year Founded:
2023
CEO
Warren Marcus



